Swiss Pharma Company Seeking $2.47M Investment for International Expansion

This listing details an investment opportunity in a well-established Swiss Pharmaceutical company located in London, UK, seeking strategic investors to fuel its next phase of international expansion. Shareholders are offering up to 20% equity, with the potential to increase to a majority share, in exchange for $2,473,720 USD (CHF 2,000,000). The company has already achieved promising international results and possesses significant untapped market opportunities. Interested parties are invited to review the comprehensive investment deck detailing the growth strategy and financial performance.